Sciact
  • EN
  • RU

Computational Assessment of Pharmacological, Toxicological, and Electronic Properties of Ephedrine Derivatives Full article

Journal Eurasian Chemico-Technological Journal
ISSN: 1562-3920
Output data Year: 2026, Volume: 26, Number: 1, Pages: 83-91 Pages count : 9 DOI: 10.18321/ectj1685
Authors Gubenko Maxim 1,2 , Ten Assel 1 , Yergaliyeva Elmira 2 , Dembitsky Valery 3 , Yu Valentina 1
Affiliations
1 A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan
2 Akhmet Baitursynuly Kostanay Regional University, 47 Baytursynov St., Kostanay 110000, Kazakhstan
3 N.D. Zelinsky Institute of Organic Chemistry, 47 Leninsky Prospekt, Moscow 119991, Russia

Abstract: Ephedrine and its derivatives have long been recognized for their therapeutic potential in the treatment of hypotension, asthma, and obesity. However, their use is limited by significant side effects, including cardiovascular risks and toxicity. This study presents a comprehensive computational evaluation of 13 ephedrine derivatives using integrated ADMET analysis, PASS prediction, and quantum-chemical approaches. Pharmacological profiles, toxicity risks, and electronic properties were systematically analyzed to establish structure–activity relationships. Key physicochemical parameters, pharmacokinetic properties, and toxicity risks were analyzed to identify compounds with optimal drug-like characteristics. The results highlight compound 5 as the most promising candidate, demonstrating high drug-likeness (Quantitative Estimate of Drug-likeness, QED = 0.85) and favorable pharmacokinetic properties. Conversely, compounds 3, 11–13 exhibit high toxicity and require structural optimization. PASS predictions indicate diverse biological activities, including spasmolytic and analeptic effects, with compounds 5–7showing significant potential for further development and compound 13 exhibiting antioxidant activity. DFT analysis of ephedrine, cephedrine and key derivatives (compounds 5, 7, 13) revealed an optimal HOMO-LUMO range (ΔE = 4.7–5.0 eV) for compounds with high activity and low toxicity, where derivative 5 exhibits the best balance. This study underscores the importance of rational drug design in optimizing therapeutic efficacy while minimizing adverse effects and environmental risks
Cite: Gubenko M. , Ten A. , Yergaliyeva E. , Dembitsky V. , Yu V.
Computational Assessment of Pharmacological, Toxicological, and Electronic Properties of Ephedrine Derivatives
Eurasian Chemico-Technological Journal. 2026. V.26. N1. P.83-91. DOI: 10.18321/ectj1685 WOS Scopus OpenAlex
Dates:
Submitted: Oct 10, 2025
Accepted: Feb 18, 2026
Published online: Apr 10, 2026
Identifiers:
≡ Web of science: WOS:001799963800006
≡ Scopus: 2-s2.0-105039100600
≡ OpenAlex: W7154997170
Altmetrics: